Cancer Mortality in Hispanic Patients Decreasing Overall, Increasing for Certain Cancers
Hispanic patients have seen increases in cancer-specific mortality for certain cancers, including liver, pancreatic, and uterine cancer.
Hispanic patients have seen increases in cancer-specific mortality for certain cancers, including liver, pancreatic, and uterine cancer.
A cancer patient’s race, type of insurance, and setting in which they are treated are all associated with end-of-life treatment, a study suggests.
Patients aged 65 years or older are underrepresented in clinical trials supporting cancer drug approvals, a study suggests.
Women belonging to racial and ethnic minority groups have the lowest adherence to breast cancer screening programs, a study suggests.
Children who have a parent with cancer are more likely than other children to experience unmet economic needs, a study suggests.
The number of patients with a prior cancer who have been diagnosed with a new cancer has increased by approximately 15% during a 6-year period, a study suggests.
Eligibility criteria may contribute to racial and ethnic disparities in enrollment in MM trials supporting drug approvals.
New research suggests that carfilzomib increases the risk of heart failure in patients with multiple myeloma, but the risk does not appear to vary between Black and White patients.
A recent study revealed a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
For adults with a history of cancer, delayed care due to lack of transportation is associated with increased ER use and all-cause mortality, a study suggests.